1512 ET - Chemours, the producer of fluorine-based refrigerants, specialty plastics and titanium dioxide pigments, is entering a more favorable environment, according to Mizuho in a research report. Analysts say one major tailwind is that industry stockpiling of the banned refrigerant Freon is normalizing amid the larger shift to next-gen refrigerants, of which Chemours is one of only two producers. The analysts also say that litigation surrounding PFAS, also known as forever chemicals, seems to be moving in the right direction. They believe a potential settlement in advance of the New Jersey PFAS trial, anticipated in spring/summer, would likely help limit the scope of Chemours' potential liability. Mizuho upgrades Chemours to outperform from neutral. Chemours is up 2.6% to $14.19. (sarina.isaacs@wsj.com)
(END) Dow Jones Newswires
March 27, 2025 15:14 ET (19:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.